Subscribe
Sign in
Home
Work with us / Advertise
CensHERship
Archive
About
Latest
Top
Discussions
Clue app secures 'substantial' investment from Verdane's €2 billion growth fund
Single largest investment in Clue to date
Jan 15
•
Anna O'Sullivan
2
1
1
💌 Issue 129: $100bn of women's health exits | Pomelo Care's $92m Series C | the menstrual blood-based precision health platform …
The global weekly briefly on women's health innovation and Femtech
Jan 14
•
Anna O'Sullivan
4
Two major partnerships expand access to Visby's at-home sexual health test for women
Quest and Labcorp now offer more choices
Jan 13
•
Anna O'Sullivan
1
Xella Health raises $3.7m pre-seed to build menstrual blood–based precision health platform
Ahead of a Spring 2026 launch the start-up is targeting a 10,000 women waitlist
Jan 12
•
Anna O'Sullivan
4
3
1
Pomelo Care raises $92 million Series C to expand beyond maternity into multi-stage women's health
Pomelo Care already supports nearly 7% of all U.S births
Jan 8
•
Anna O'Sullivan
1
💌 Issue #128: The business of women's health starts here
19 expert predictions and 8 top stories to have on your radar as we head into 2026
Jan 7
•
Anna O'Sullivan
26
1
4
19 experts predict what's in store for Femtech and women's health in 2026
Key insights from the people closest to innovation, policy and strategy in women's health
Jan 7
•
Anna O'Sullivan
6
2
1
Eli Health launches progesterone and testosterone real-time saliva test
Progesterone is a foundational female health hormone
Jan 6
•
Anna O'Sullivan
3
1
2
Bactolife secures €30m Series B to commercialise gut health ingredient
Danish company has US launch planned for 2026 and focus on women and children
Jan 6
•
Anna O'Sullivan
December 2025
💌 Issue 127: 2025's defining moments | University spin-out secures £3.5m pre-seed | FemTech Portugal and FemTech Spain launch | FDA expands…
The global weekly briefing on women's health innovation and FemTech
Dec 17, 2025
•
Anna O'Sullivan
8
2025 in review: 17 defining moments that will shape women’s health in 2026
We’ve passed the inflection point in women’s health and the foundations have begun to take shape.
Dec 17, 2025
•
Anna O'Sullivan
and
Anastasiya Markvarde
24
3
3
FDA expands Addyi approval to include postmenopausal women, closing a long-standing gap in sexual health care
First and only FDA-approved pill for treatment of HSDD in both premenopausal and postmenopausal women.
Dec 16, 2025
•
Anna O'Sullivan
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
